Acumen Pharmaceuticals

1 follower


Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers.

Industries

Employees

11-50

Links

Org chart

Daniel O’Connell
President & CEO

Daniel O’Connell

Collapse
Russell Barton
Chief Operating Officer
Matthew Zuga
CFO & Chief Business Officer
Eric Siemers
Chief Medical Officer
Derek Meisner
Chief Legal Officer
Julie Bockenstette
EVP & Head of Human Resources
Alex Braun
VP, Head of Investor Relations
Jerry Moore
Senior Advisor, Nonclinical Development
Kristen Elkins
Project Manager